May 24 2025
A new double-blind, placebo-controlled crossover study has found that cannabidiol (CBD) led to behavioral improvements in about two-thirds of boys with autism spectrum disorder, though researchers emphasize that a strong placebo effect complicates interpretation of the results. Conducted by the University of California San Diego School of Medicine and published in the Journal of Autism …
May 22 2025
A study published today by the American Journal of Public Health finds that Canada’s legalization of marijuana was associated with a sharp decline in cannabis-related hospitalizations among youth under the minimum legal age (MLA), suggesting age restrictions may help protect young people. Researchers from the University of Ottawa, University of Southern California, University of Toronto, and …
May 22 2025
A study published today by the International Journal of Pharmaceutics finds that nanoencapsulated cannabidiol (CBD) may significantly reduce panic-like behaviors. Researchers from the University of São Paulo, the Federal University of Rio Grande do Sul, and the University of Poonch Rawalakot explored how nanoencapsulation—specifically, polymeric lipid core-based technology—affects CBD’s impact on defensive behaviors triggered by exposure …
May 22 2025
A new study published in Neuropharmacology has found that an ultra-low dose of cannabidiol (CBD) may effectively reverse some of the behavioral and molecular effects of chronic stress, a major factor contributing to depression. Researchers from the University of Barcelona and the University of Greifswald administered a low dose of CBD (1 mg/kg) to mice …
May 21 2025
A study published in the journal Scientific Reports has found that adding far-red light at the end of the day can significantly boost THC levels in some cannabis strains while reducing overall energy consumption. For the study, researchers from Australia compared six lighting treatments across three popular genotypes—Cannatonic, Hindu Kush, and Northern Lights—exploring whether a …
May 20 2025
A team of chemists at the University of California, Davis has developed a modified version of LSD that may offer the drug’s therapeutic benefits without its mind-altering effects. The newly created compound, known as JRT, maintains LSD’s ability to stimulate brain cell growth, a promising effect for treating conditions like depression and schizophrenia. But unlike …
May 20 2025
A new systematic review published in the journal Cureus finds that psychedelic-assisted therapies such as ketamine, esketamine, and psilocybin may offer fast-acting and sustained relief for those with treatment-resistant depression (TRD), while also improving real-world functioning. The review analyzed 10 randomized controlled trials published within the past year, all of which assessed various psychedelic agents …
May 20 2025
Researchers have identified two cannabinoids and three other bioactive compounds in Rhododendron, a plant native to Pakistan that has long been used in traditional medicine. In a study published in Natural Product Research, scientists from the University of Swat and the Royal Botanic Gardens Kew in the UK analyzed the leaves of Rhododendron anthopogon, a …
May 20 2025
According to the results of a new study published in Inflammopharmacology, full-spectrum cannabis sativa extract (FSC) may offer significant benefits in protecting the gut and peripheral organs following an ischemic stroke. Researchers from Brazil, Canada, and the United States examined the effects of FSC on male Wistar rats that underwent a 60-minute middle cerebral artery …
May 19 2025
A study published today by the journal Developmental Neurobiology found that cannabidiol (CBD) oil may improve core symptoms of autism and reduce oxidative stress. Researchers from several Pakistani institutions, including the National University of Sciences and Technology and Quaid-i-Azam University, examined the effects of CBD oil on mice with autism-like behaviors induced by valproic acid …
